- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Precision Oncology Clinical Service Partnership Announced
The integrated cancer services offered by Sarah Cannon will soon be supported by the personalized medicine technology platform of Syapse, to improve individualized patient care, the companies have announced.
Sarah Cannon the global cancer enterprise of Hospital Corporation of America (HCA) which offers cutting-edge clinical research alongside integrated cancer services and Syapse the leading provider of precision medicine software announced plans today to launch a precision oncology clinical service collaboration. The software-based service is designed to support Sarah Cannon’s efforts to make tumor genome profiling a key component of the care continuum for the more than 100000 newly diagnosed cancer patients seen annually across its network of cancer centers throughout the United States and United Kingdom.
Leaders from both organizations served on a panel to discuss genomic profiling in routine clinical care at the Personalized Medicine World Conference in Mountain View Calif. on January 27. The precision oncology platform to be launched in the second half of 2015 will assist in treatment planning and clinical decision-making by enabling Sarah Cannon care providers access to genomic testing best practice guidelines and decision support. It will also allow Sarah Cannon’s personalized medicine team to streamline genomic data analysis to improve patient outcomes and expand clinical trial options for patients.
Read the complete press release: http://bit.ly/1A79uOj
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
